Acute leukaemia, Acute lymphoblastic leukaemia (ALL), Children's cancers, Leukaemia
Results
Phase 1
This trial was for children and young people with acute lymphoblastic leukaemia (ALL) that either:
had come back after treatment
was likely to come back after treatment
Children and young people with a leukaemia that had the CD19 or CD22 protein could take part.
The trial was open for people to join between 2016 and 2021. The team reported results in 2019 and 2024.
Recruitment start: 25 April 2016
Recruitment end: 30 November 2021
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Persis Amrolia
University College London (UCL)
Children with Cancer UK
Great Ormond Street Hospital Children’s Charity
JP Moulton Charitable Foundation
Autolus Ltd
Last reviewed: 2 October 2024
CRUK internal database number: 14118
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
